SCHEMBL18853088

SCHEMBL18853088

CC1(C)c2cc3ccccc3cc2-c2nc(-c3ccccc3)ncc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 1/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ LMNA P02545 4/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ MAPT P10636 2/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ RECQL P46063 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.37
▸ ALDH1A1 P00352 3/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ NFKB1 P19838 1/20 0.36
▸ NFKB2 Q00653 1/20 0.36
▸ RELA Q04206 1/20 0.36
▸ HPGDS O60760 2/20 0.35
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18853188 0.84 L3MBTL1 (0.44) EGFRKMT2AMEN1L3MBTL1LMNA
SCHEMBL18853501 0.80 MAPT (0.38) EGFRKMT2AMEN1L3MBTL1LMNA
SCHEMBL18853082 0.78 ADK (0.38) KMT2AMEN1L3MBTL1LMNASMN1; SMN2
SCHEMBL18852963 0.77 MAPT (0.48) EGFRKMT2AMEN1L3MBTL1LMNA
SCHEMBL18853098 0.76 ALDH1A1 (0.37) KMT2AMEN1L3MBTL1LMNASMN1; SMN2
SCHEMBL18853122 0.76 ALDH1A1 (0.37) KMT2AMEN1L3MBTL1LMNASMN1; SMN2
SCHEMBL18852996 0.75 DPP4 (0.36) KMT2AMEN1L3MBTL1LMNAMAPT
SCHEMBL18852983 0.75 DPP4 (0.36) KMT2AMEN1L3MBTL1LMNAMAPT
SCHEMBL29669986 0.74 SMN1; SMN2 (0.39) KMT2AL3MBTL1LMNASMN1; SMN2MAPT
SCHEMBL18853070 0.74 DPP4 (0.36) KMT2AMEN1L3MBTL1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10680190-B2 Organic compound, organic optoelectronic element, and display device SAMSUNG SDI CO., LTD. (KR) 2020-06-09 — — US disclosed
US-20170141331-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE SAMSUNG SDI CO.,LTD. (KR) 2017-05-18 — — US disclosed
US-20170141331-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE SAMSUNG SDI CO.,LTD. (KR) 2017-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170141331-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE OCIAD1, OXER1, OCIAD2 EGFR 462/4885KMT2A 3186/4885MEN1 1335/4885
US-10680190-B2 Organic compound, organic optoelectronic element, and display device OCIAD1, OXER1, OCIAD2 EGFR 462/4885KMT2A 3186/4885MEN1 1335/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback